NexMed Signs Global Licensing Deal with Novartis
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 64 (Table of Contents)
Published: 5 Oct-2005
DOI: 10.3833/pdr.v2005.i64.618 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
NexMed has licensed a nail fungal infection treatment that utilizes its proprietary drug delivery technology NexACT® to Novartis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS